In re Northfield Laboratories Inc. Securities Litigation

264 F.R.D. 407, 2009 U.S. Dist. LEXIS 114379, 2009 WL 4639678
CourtDistrict Court, N.D. Illinois
DecidedDecember 8, 2009
DocketNo. 06 C 1493
StatusPublished
Cited by2 cases

This text of 264 F.R.D. 407 (In re Northfield Laboratories Inc. Securities Litigation) is published on Counsel Stack Legal Research, covering District Court, N.D. Illinois primary law. Counsel Stack provides free access to over 12 million legal documents including statutes, case law, regulations, and constitutions.

Bluebook
In re Northfield Laboratories Inc. Securities Litigation, 264 F.R.D. 407, 2009 U.S. Dist. LEXIS 114379, 2009 WL 4639678 (N.D. Ill. 2009).

Opinion

MEMORANDUM OPINION AND ORDER

NAN R. NOLAN, United States Magistrate Judge.

Five plaintiffs have filed this securities fraud class action lawsuit on behalf of “all persons who purchased” Northfield Laboratories Inc. stock between March 19, 2001 and March 20, 2006 (the putative “Class Period”). Northfield is a development stage company that engages in research, development, testing, and manufacturing of a hemoglobin-based blood substitute (“PolyHeme”) for the treatment of urgent, life-threatening blood loss in trauma and resultant surgical settings. Defendants Steven A. Gould, M.D. and Richard E. DeWoskin founded North-field in 1985 and have both served at times as its Chairman and CEO. Plaintiffs allege that Defendants engaged in a scheme to defraud investors into purchasing stock at artificially inflated prices by making false and misleading statements regarding (1) the success of Northfield’s ongoing elective surgery clinical trials; (2) the occurrence of serious adverse events in the elective surgery trial that were possibly related to PolyHeme; (3) the reasons why Northfield’s Phase III trial of Poly-Heme for elective surgery was terminated; (4) the fact that the elective surgery trial was terminated in its entirety; and (5) the increased risks for obtaining market approval for PolyHeme’s use in elective surgery as a result of the serious adverse events in the elective surgery trial. Plaintiffs claim that [409]*409these actions violated Sections 10(b) and 20(a) of the Securities Exchange Act of 1934, 15 U.S.C. § 78j(b) and 78t(a), and Rule 10b-5 promulgated thereunder, 17 C.F.R. § 240.10b-5.

The district court denied motions to dismiss Plaintiffs’ Second Amended Complaint; bifurcated discovery on the issues of class certification and liability; and referred the matter to this court for supervision. (Memorandum Opinion and Order of 9/23/08, Doc. 168; Minute Order of 10/14/08, Doc. 174; Transcript of 10/14/08 Status, Doc. 178.) On April 9, 2009, Northfield filed a motion to compel production of documents and information. Defendant Gould subsequently joined in the motion after Northfield filed a voluntary petition for bankruptcy in the District of Delaware. On June 9, 2009, however, the district court stayed the entire case pending resolution of the bankruptcy proceedings. (Minute Order of 6/9/09, Doc. 243.) In light of the stay, this court denied the motion to compel without prejudice. (Minute Order of 6/10/09, Doc. 244.)

On November 13, 2009, the district court lifted the stay as to individual Defendants Gould and DeWoskin. (Minute Order of 11/13/09, Doc. 267.) This court reinstated the motion to compel, and now grants it in part and denies it in part.

DISCUSSION

The Federal Rules permit discovery regarding any matter, not privileged, that is relevant to the claim or defense of any party. Fed. R. Civ. P. 26(b)(1). “Mutual knowledge of all the relevant facts gathered by both parties is essential to proper litigation. To that end, either party may compel the other to disgorge whatever facts he has in his possession.” In re Thomas Consolidated Indus., Inc., No. 04 C 6185, 2005 WL 3776322, at *6 (N.D.Ill. May 19, 2005), aff'd 456 F.3d 719 (7th Cir.2006).(quoting Hickman v. Taylor, 329 U.S. 495, 507, 67 S.Ct. 385, 91 L.Ed. 451 (1947)).

In this motion, Defendants seek to compel Plaintiffs to produce copies of their trading records in Northfield and other securities. Defendants also want additional information relating to the corrective disclosures, set forth in Plaintiffs’ Second Amended Complaint, that allegedly caused Northfield’s stock to drop in price. Specifically, Defendants claim that they are entitled to know what information in those disclosures was “new” to the market. The court addresses each category in turn.

A. Investment Histories

In Document Request Nos. 1, 5 and 18, Defendants seek to compel the account statements evidencing Plaintiffs’ securities trading records. The requests include both transactions in Northfield securities during the Class Period (March 19, 2001 through March 20, 2006), and transactions in other public securities from January 1, 2001 to the present.

1. Northfield Securities

Plaintiffs claim that they have already produced all relevant information relating to their purchase and sale of Northfield stock in the form of “trade confirmations.” These trade confirmations reflect the date, price, number and type of each Northfield security Plaintiffs bought and sold during the Class Period. In Plaintiffs’ view, “there is no reasonable basis to force the Plaintiffs to search and obtain over 60 months worth of account statements to ‘corroborate’ trade confirmations from the same brokerage accounts that issued them.” (PI. Resp., at 3^4.) Defendants disagree, arguing that they are not required to accept Plaintiffs’ word that they did not engage in any other Northfield transactions.

In the court’s view, Defendants are indeed entitled to test the accuracy and completeness of Plaintiffs’ trade confirmations. See, e.g., Rivera v. Heights Landscaping, Inc., No. 03 C 6428, 2004 WL 434214, at *2 (N.D.Ill. Mar.5, 2004) (“[P]laintiffs are entitled to test the accuracy of [defendant’s] proffered financial information if they choose to do so.”) Plaintiffs therefore must produce account statements evidencing their trading in Northfield securities during the Class Period. The court is not persuaded by Plaintiffs’ objection that the request is unduly burdensome. To date, Plaintiffs have pro[410]*410duced only 30 pages of documents to Defendants. The account statements at issue are certainly within Plaintiffs’ control, and they must contact the appropriate brokers to obtain copies.

2. Other Securities

With respect to Plaintiffs’ trading history in securities other than Northfield, Defendants argue that the information is relevant to test the typicality of Plaintiffs’ claims and defenses and, thus, their adequacy as class representatives. The court accepted a similar argument in Feldman v. Motorola, Inc., No. 90 C 5887, 1992 WL 137163 (N.D.Ill. June 10, 1992), where the defendants sought the plaintiffs’ brokerage account statements in order to “rebut the presumption of reliance” on the market. Id. at *1. The court first concluded that the statements were “relevant to the merits of plaintiffs’ federal securities law claim” because they could lead to evidence that the plaintiffs were ‘“sophisticated investors’ who purchased their shares in reliance on factors other than market price.” Id.

This did not end the inquiry, however, because the defendants wanted the brokerage statements at the class certification stage. The court acknowledged a split of authority as to whether sophisticated investors who do not rely on the market are appropriate class representatives, but nonetheless held that “a plaintiffs investment history could reveal unusual typicality defenses.” Id. at *2 (citing Shields v. Smith, No. C-90-0349-FMS, 1991 WL 319032, at *3 (N.D.Cal. Nov.

Free access — add to your briefcase to read the full text and ask questions with AI

Related

Flores v. Guevara
N.D. Illinois, 2024
Seeks v. The Boeing Company
N.D. Illinois, 2019

Cite This Page — Counsel Stack

Bluebook (online)
264 F.R.D. 407, 2009 U.S. Dist. LEXIS 114379, 2009 WL 4639678, Counsel Stack Legal Research, https://law.counselstack.com/opinion/in-re-northfield-laboratories-inc-securities-litigation-ilnd-2009.